Literature DB >> 11349609

Allergic ocular disease. A review of pathophysiology and clinical presentations.

L Bielory1, P E Goodman, E M Fisher.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11349609     DOI： 10.1385/CRIAI:20:2:183

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  63 in total

1.  Occurrence of cataracts and keratoconus with atopic dermatitis.

Authors:  L A BRUNSTING; W B REED; H L BAIR
Journal:  AMA Arch Derm       Date:  1955-09

2.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Trans Am Ophthalmol Soc       Date:  1952

3.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Am J Ophthalmol       Date:  1953-07       Impact factor: 5.258

Review 4.  Giant papillary conjunctivitis.

Authors:  M R Allansmith; R N Ross
Journal:  Int Ophthalmol Clin       Date:  1988

5.  Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis.

Authors:  A M Irani; S I Butrus; K F Tabbara; L B Schwartz
Journal:  J Allergy Clin Immunol       Date:  1990-07       Impact factor: 10.793

6.  Eczema and keratoconus.

Authors:  P W Copeman
Journal:  Br Med J       Date:  1965-10-23

7.  Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.

Authors:  J W Oh; J C Shin; S J Jang; H B Lee
Journal:  Ann Allergy Asthma Immunol       Date:  1999-06       Impact factor: 6.347

8.  Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.

Authors:  P Søhoel; B A Freng; J Kramer; S Poppe; R Rebo; F R Korsrud; O Garud; O J Woxen; A K Olsen
Journal:  J Allergy Clin Immunol       Date:  1993-07       Impact factor: 10.793

9.  Atopic keratoconjunctivitis.

Authors:  C S Foster; M Calonge
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

10.  Rapid appearance of plasmin in tear fluid after ocular allergen exposure.

Authors:  E M Salonen; J Lauharanta; P S Sim; R Stephens; A Vaheri
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330
View more
  1 in total

1.  Comparative study of the ocular efficacy and safety of diclofenac sodium (0.1%) ophthalmic solution with that of ketorolac tromethamine (0.5%) ophthalmic solution in patients with acute seasonal allergic conjunctivitis.

Authors:  Navdeep Dehar; Anita Gupta; Gursatinder Singh
Journal:  Int J Appl Basic Med Res       Date:  2012-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.